Mogelijk gemaakt door Google TranslateTranslate
Latest Press Releases
View all
TimeHeadline
9m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
35m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
35m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
36m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
36m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Urogen Pharma Ltd logo

Urogen Pharma Ltd

About

Urogen Pharma Ltd (NASDAQ:URGN) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 8 2026
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
Mar 30 2026
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
Mar 13 2026
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
Mar 2 2026
UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 2 2026
UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors

Financials

Revenue
$109.79 M
Market Cap
$916.2 M
EPS
-3.19

Community Chat

Ask AI

6ix6ixAIEvents
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren